Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Bob Pinedo Cancer Care Award 2022 for Laurence Zitvogel
Laurence Zitvogel, french oncologist at Gustave Roussy is receiving this year’s Bob Pinedo Cancer Care Award for her pioneering research and passionate commitment to improving the quality of treatment and care for cancer patients.
Published on
Changed on
Laurence Zitvogel, french oncologist at Gustave Roussy is receiving this year’s Bob Pinedo Cancer Care Award for her pioneering research and passionate commitment to improving the quality of treatment and care for cancer patients.
Internationally recognized for her major discoveries in the field of cancer microbiota, she is one of the women scientists who actively contribute to the advancement of cancer research, particularly in the fields of immunology and immunotherapy, by combining basic and translational research.
Laurence Zitvogel’s research about the gut microbiome is crucial in the efficacy of both chemotherapy and immunotherapy. By pointing out the key role of the immune system in anticancer therapy efficacy, future treatments can be better adapted to the individual patient.
The jury, chaired by Pancras Hogendoorn (Academy member and professor of pathology at Leiden University Medical Center), has deemed Laurence Zitvogel a laureate of the Bob Pinedo Cancer Care Award.
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
